SALT LAKE CITY, Aug. 14 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX: BSM) today announced that the company has signed an exclusive patent license agreement with Duke University for rights...
SALT LAKE CITY, July 31 /PRNewswire-FirstCall/ -- BSD Medical Corp. today announced that the Company has filed the response to FDA's questions on the Premarket Approval Application (PMA...
SALT LAKE CITY, July 25 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX: BSM) today announced that the Department of Radiation Oncology of the Erlangen University Medical School has placed an...
SALT LAKE CITY, June 15 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMX: BSM) said today that the company has filed a patent for a new non-invasive phased array breast treatment applicator...
SALT LAKE CITY, Jan. 4 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX: BSM) today announced that the company has entered into a distribution agreement with Ktec Corporation to sell BSD's...
SALT LAKE CITY, Dec. 27 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX: BSM) today announced that the company is near to concluding agreements with sales entities in preparation for entry...
NEW YORK, Nov. 28 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) will launch trading in options on Tuesday, November 29, 2005 on the following American Stock Exchange and New York...
BSD Medical's MRI-Integrated System Precisely Monitors Cancer Hyperthermia Noninvasively, According to Study Published in Cancer Research BSD's Groundbreaking Use of Magnetic Resonance...
American Stock Exchange Lists Common Shares of BSD Medical Corporation NEW YORK, June 9 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today listed common shares of BSD Medical...
BSD Medical Corporation to Begin Trading on Amex as BSM SALT LAKE CITY, June 9 /PRNewswire-FirstCall/ -- BSD Medical Corporation (AMEX:BSM) today announced that the company will begin trading on...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約